BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 11698027)

  • 1. Neuropathic pain: a possible role for the melanocortin system?
    Vrinten DH; Kalkman CJ; Adan RA; Gispen WH
    Eur J Pharmacol; 2001 Oct; 429(1-3):61-9. PubMed ID: 11698027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antagonism of the melanocortin system reduces cold and mechanical allodynia in mononeuropathic rats.
    Vrinten DH; Gispen WH; Groen GJ; Adan RA
    J Neurosci; 2000 Nov; 20(21):8131-7. PubMed ID: 11050135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic blockade of melanocortin receptors alleviates allodynia in rats with neuropathic pain.
    Vrinten DH; Adan RA; Groen GJ; Gispen WH
    Anesth Analg; 2001 Dec; 93(6):1572-7, table of contents. PubMed ID: 11726447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melanocortins and cardiovascular regulation.
    Versteeg DH; Van Bergen P; Adan RA; De Wildt DJ
    Eur J Pharmacol; 1998 Oct; 360(1):1-14. PubMed ID: 9845266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction between the spinal melanocortin and opioid systems in a rat model of neuropathic pain.
    Vrinten DH; Gispen WH; Kalkman CJ; Adan RA
    Anesthesiology; 2003 Aug; 99(2):449-54. PubMed ID: 12883419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The melanocortin system in articular chondrocytes: melanocortin receptors, pro-opiomelanocortin, precursor proteases, and a regulatory effect of alpha-melanocyte-stimulating hormone on proinflammatory cytokines and extracellular matrix components.
    Grässel S; Opolka A; Anders S; Straub RH; Grifka J; Luger TA; Böhm M
    Arthritis Rheum; 2009 Oct; 60(10):3017-27. PubMed ID: 19790046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of melanocortin receptors and pro-opiomelanocortin in the rat spinal cord in relation to neurotrophic effects of melanocortins.
    van der Kraan M; Tatro JB; Entwistle ML; Brakkee JH; Burbach JP; Adan RA; Gispen WH
    Brain Res Mol Brain Res; 1999 Jan; 63(2):276-86. PubMed ID: 9878783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of melanocortins and their receptors in inflammatory processes, nerve regeneration and nociception.
    Starowicz K; Przewłocka B
    Life Sci; 2003 Jul; 73(7):823-47. PubMed ID: 12798410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pro-opiomelanocortin (POMC) deficiency and peripheral melanocortins in obesity.
    Zemel MB; Shi H
    Nutr Rev; 2000 Jun; 58(6):177-80. PubMed ID: 10885325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New aspects on the melanocortins and their receptors.
    Wikberg JE; Muceniece R; Mandrika I; Prusis P; Lindblom J; Post C; Skottner A
    Pharmacol Res; 2000 Nov; 42(5):393-420. PubMed ID: 11023702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The melanocortin-1 receptor and human pigmentation.
    Abdel-Malek Z; Suzuki I; Tada A; Im S; Akcali C
    Ann N Y Acad Sci; 1999 Oct; 885():117-33. PubMed ID: 10816645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical picture of neuropathic pain.
    Jensen TS; Gottrup H; Sindrup SH; Bach FW
    Eur J Pharmacol; 2001 Oct; 429(1-3):1-11. PubMed ID: 11698022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melanocortins and the brain: from effects via receptors to drug targets.
    Adan RA; Gispen WH
    Eur J Pharmacol; 2000 Sep; 405(1-3):13-24. PubMed ID: 11033310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of melanocortins in body weight regulation: opportunities for the treatment of obesity.
    MacNeil DJ; Howard AD; Guan X; Fong TM; Nargund RP; Bednarek MA; Goulet MT; Weinberg DH; Strack AM; Marsh DJ; Chen HY; Shen CP; Chen AS; Rosenblum CI; MacNeil T; Tota M; MacIntyre ED; Van der Ploeg LH
    Eur J Pharmacol; 2002 Aug; 450(1):93-109. PubMed ID: 12176114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of melanocortins in body weight regulation: opportunities for the treatment of obesity.
    MacNeil DJ; Howard AD; Guan X; Fong TM; Nargund RP; Bednarek MA; Goulet MT; Weinberg DH; Strack AM; Marsh DJ; Chen HY; Shen CP; Chen AS; Rosenblum CI; MacNeil T; Tota M; MacIntyre ED; Van der Ploeg LH
    Eur J Pharmacol; 2002 Apr; 440(2-3):141-57. PubMed ID: 12007532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Receptor-mediated modulation of murine mast cell function by alpha-melanocyte stimulating hormone.
    Adachi S; Nakano T; Vliagoftis H; Metcalfe DD
    J Immunol; 1999 Sep; 163(6):3363-8. PubMed ID: 10477606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of functional melanocortin receptors and proopiomelanocortin peptides by human dermal microvascular endothelial cells.
    Scholzen TE; Brzoska T; Kalden DH; Hartmeyer M; Fastrich M; Luger TA; Armstrong CA; Ansel JC
    Ann N Y Acad Sci; 1999 Oct; 885():239-53. PubMed ID: 10816657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Asp10 in Lys-gamma2-MSH determines selective activation of the melanocortin MC3 receptor.
    Oosterom J; Burbach JP; Gispen WH; Adan RA
    Eur J Pharmacol; 1998 Jul; 354(1):R9-11. PubMed ID: 9726642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of alpha-melanocyte-stimulating hormone in cutaneous biology.
    Luger TA; Scholzen T; Grabbe S
    J Investig Dermatol Symp Proc; 1997 Aug; 2(1):87-93. PubMed ID: 9487022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous and exogenous melanocortin antagonists induce anti-allodynic effects in a model of rat neuropathic pain.
    Bertorelli R; Fredduzzi S; Tarozzo G; Campanella M; Grundy R; Beltramo M; Reggiani A
    Behav Brain Res; 2005 Feb; 157(1):55-62. PubMed ID: 15617771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.